​

Funding Round

Series C - Oculis

Series C - Oculis

Investment Firm

Overview

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

Announced Date

May 04, 2021

Closed on Date

May 04, 2021

Funding Type

Series C

Highlights

Location

Europe

Social

Investor Lead

BVCF

BVCF

BVCF is a early_stage_venture and late_stage_venture firm.

Hyfinity Investments

Hyfinity Investments

Hyfinity Investments is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

10

Investor Name
Participant InvestorNovartis Venture Fund
Participant InvestorVI Partners
Participant InvestorBay City Capital
Participant InvestorBrunnur Ventures
Participant InvestorEarlybird Venture Capital

Round Details and Background

Oculis raised $57000000 on 2021-05-04 in Series C

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2012
Grant - Oculis
1-63.6K
Mar 01, 2011
Grant - Oculis
1-224.6K
Mar 01, 2015
Grant - Oculis
1-112.6K
Aug 16, 2016
Series A - Oculis
2-undefined

Recent Activity

There is no recent news or activity for this profile.